The role of B vitamins in preventing and treating cognitive impairment and decline

Advances in Nutrition

Volumn 3, Issue 6, 2012, Pages 801-812

  Morris, Martha Savaria ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B COMPLEX;

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; HUMAN; METABOLISM; METHYLATION; REVIEW; VITAMIN DEFICIENCY;

ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; FOLIC ACID; HOMOCYSTEINE; HUMANS; METHYLATION; VITAMIN B 12; VITAMIN B COMPLEX; VITAMIN B DEFICIENCY;

EID: 84875329449     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.112.002535     Document Type: Review

References (120)

1. Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry. 1997;38:305-14.
2. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975;22:215-27.
3. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-8.
4. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313-7.
5. Driscoll I, Sutherland RJ. The aging hippocampus:navigating between rat and human experiments. Rev Neurosci. 2005;16:87-121.
6. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580:2994-3005.
7. Smulders YM, Blom HJ. The homocysteine controversy. J Inherit Metab Dis. 2011;34:93-9.
8. Bottiglieri T. S-Adenosyl-L-methionine (SAMe):from the bench to the bedside-molecular basis of a pleiotrophic molecule. Am J Clin Nutr. 2002;76:1151S-7S.
9. Selhub J, Troen A, Rosenberg IH. B vitamins and the aging brain. Nutr Rev. 2010;68:Suppl 2:S112-8.
10. Metz J. Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr. 1992;12:59-79.
11. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337:1441-8.
12. De Gennes L, Bensoussan P, Klein F. [Addison's disease; acute mental disorders and chronic delirium]. Ann Med Psychol (Paris). 1954;112:522-7.
13. Carmel R. Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch Intern Med. 1988;148:1712-4.
14. Allen RH, Stabler SP, Lindenbaum J. Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders. Eur J Pediatr. 1998;157:Suppl 2:S122-6.
15. Scott E. Prevalence of pernicious anaemia in Great Britain. J Coll Gen Pract. 1960;3:80-4.
16. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification:results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-50.
17. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population:ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr. 1999;70:904-10.
18. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60:2-11.
19. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr. 2002;132:2799-803.
20. Björkegren K, Svardsudd K. Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes-a population-based study. J Intern Med. 2001;249:423-32.
21. Carmel R. Mean corpuscular volume and other concerns in the study of vitamin B-12 deficiency:epidemiology with pathophysiology. Am J Clin Nutr. 2008;87:1962-3; author reply 3-4.
22. Andrès E, Perrin AE, Demangeat C, Kurtz JE, Vinzio S, Grunenberger F, Goichot B, Schlienger JL. The syndrome of food-cobalamin malabsorption revisited in a department of internal medicine. A monocentric cohort study of 80 patients. Eur J Intern Med. 2003; 14:221-6.
23. Carmel R. Subclinical cobalamin deficiency. Curr Opin Gastroenterol. 2012;28:151-8.
24. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-7.
25. Larkin M. Kilmer McCully:pioneer of the homocysteine theory. Lancet. 1998;352:1364.
26. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand. 1992;86:386-90.
27. Riggs KM, Spiro, 3rd A, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996;63:306-14.
28. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449-55.
29. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004; 17:371-83, quiz 85-7.
30. Raman G, Tatsioni A, Chung M, Rosenberg IH, Lau J, Lichtenstein AH, Balk EM. Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr. 2007;137:1789-94.
31. Smith AD. The worldwide challenge of the dementias:a role for B vitamins and homocysteine? Food Nutr Bull. 2008; 29 Suppl 2:S143-72.
32. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function:a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2012;29:133-49.
33. Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function:a systematic review of randomized trials. Arch Intern Med. 2007;167:21-30.
34. Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B vitamins, on cognitive decline:meta-analysis of randomized trials. Am J Med. 2010;123:522-7.e2.
35. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. 2008; (4):CD004514.
36. Vogel T, Dali-Youcef N, Kaltenbach G, Andres E. Homocysteine, vitamin B12, folate and cognitive functions:a systematic and critical review of the literature. Int J Clin Pract. 2009;63:1061-7.
37. de Jager CA, Kovatcheva A. Summary and discussion:Methodologies to assess long-term effects of nutrition on brain function. Nutr Rev. 2010;68:Suppl 1:S53-8.
38. Kim JM, Stewart R, Kim SW, Shin IS, Yang SJ, Shin HY, Yoon JS. Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry. 2008;79:864-8.
39. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004; 62:1972-6.
40. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002;33:2351-6.
41. Kivipelto M, Annerbo S, Hultdin J, Backman L, Viitanen M, Fratiglioni L, Lokk J. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease:a prospective study. Eur J Neurol. 2009; 16:808-13.
42. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 2004;80:114-22.
43. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-83.
44. Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN, Green R, Miller JW. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2005;82:1346-52.
45. RavagliaG, Forti P, Maioli F, Martelli M, Servadei L, BrunettiN, Porcellini E, Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82:636-43.
46. Redéen S, Ryberg A, Petersson F, Eriksson O, Nagga K, Borch K. Homocysteine levels in chronic gastritis and other conditions:relations to incident cardiovascular disease and dementia. Dig Dis Sci. 2010;55:351-8.
47. Zylberstein DE, Lissner L, Bjorkelund C, Mehlig K, Thelle DS, Gustafson D, Ostling S, Waern M, Guo X, Skoog I. Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging. 2011;32:380-6.
48. Hooshmand B, Solomon A, Kareholt I, Leiviska J, Rusanen M, Ahtiluoto S, Winblad B, Laatikainen T, Soininen H, Kivipelto M. Homocysteine and holotranscobalamin and the risk of Alzheimer disease:a longitudinal study. Neurology. 2010;75:1408-14.
49. Mazza A, Bossone E, Mazza F, Distante A. Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis. 2005;15:118-24.
50. Mazza A, Giugliano D, Motti C, Cortese C, Andreotti F, Marra G, Nulli A. Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients. Atherosclerosis. 2000;149:223-4.
51. Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med. 2003;41:1478-88.
52. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007;64:86-92.
53. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology. 2001;56:1188-94.
54. Corrada MM, Kawas CH, Hallfrisch J, Muller D, Brookmeyer R. Reduced risk of Alzheimer's disease with high folate intake:The Baltimore Longitudinal Study of Aging. Alzheimer Dement. 2005;1:11-8.
55. Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias JL, Aggarwal NT. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis. 2006;9:435-43.
56. Shane B. Folate status assessment history:implications for measurement of biomarkers in NHANES. Am J Clin Nutr. 2011;94:337S-42S.
57. Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Minimental State Examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007;19:647-56.
58. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects:the Rotterdam Study. Am J Epidemiol. 1999;150:283-9.
59. Budge MM, de Jager C, Hogervorst E, Smith AD. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002;50:2014-8.
60. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr. 2002;75:908-13.
61. Robbins MA, Elias MF, Budge MM, Brennan SL, Elias PK. Homocysteine, type 2 diabetes mellitus, and cognitive performance:The Maine-Syracuse Study. Clin Chem Lab Med. 2005;43:1101-6.
62. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol. 2003;53:214-21.
63. Feng L, Ng TP, Chuah L, Niti M, Kua EH. Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults:findings from the Singapore Longitudinal Ageing Study. Am J Clin Nutr. 2006;84:1506-12.
64. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr. 2003;77:668-73.
65. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL. Total homocysteine and cognition in a tri-ethnic cohort:the Northern Manhattan Study. Neurology. 2004;63:254-60.
66. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, Schneede J, Ueland PM, Nexo E, Scott J, et al. Clinical relevance of low serum vitamin B12 concentrations in older people:the Banbury B12 study. Age Ageing. 2006;35:416-22.
67. Hooshmand B, Solomon A, Kareholt I, Rusanen M, Hanninen T, Leiviska J, Winblad B, Laatikainen T, Soininen H, Kivipelto M. Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly:a longitudinal study. J Intern Med. 2012;271:204-12.
68. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro, 3rd A. High homocysteine and low B vitamins predict cognitive decline in aging men:the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005; 82:627-35.
69. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, Molloy A, Evans JG. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr. 2007;86:1384-91.
70. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RG, de Craen AJ. Homocysteine, vitamin B-12, and folic acid andthe risk of cognitive decline in old age:the Leiden 85-Plus study. Am J Clin Nutr. 2005;82:866-71.
71. De Jager CA, Hogervorst E, Combrinck M, Budge MM. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med. 2003;33:1039-50.
72. Narayan SK, Saxby BK, Firbank MJ, O'Brien JT, Harrington F, McKeith IG, Hansrani M, Stansby G, Ford GA. Plasma homocysteine and cognitive decline in older hypertensive subjects. Int Psychogeriatr. 2011;23:1607-15.
73. Gallagher D, Mhaolain AN, Coen R, Walsh C, Kilroy D, Belinski K, Bruce I, Coakley D, Walsh JB, Cunningham C, et al. Detecting prodromal Alzheimer's disease in mild cognitive impairment:utility of the CAMCOG and other neuropsychological predictors. Int J Geriatr Psychiatry. 2010;25:1280-7.
74. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2001;73:927-33.
75. Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM. Homocysteine and cognitive function in the elderly:the Rotterdam Scan Study. Neurology. 2002;59:1375-80.
76. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham offspring study:age is important. Am J Epidemiol. 2005;162:644-53.
77. Clark MS, Guthrie JR, Dennerstein L. Hyperhomocysteinemia is associated with lower performance on memory tasks in post-menopausal women. Dement Geriatr Cogn Disord. 2005;20:57-62.
78. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc. 2005;53:381-8.
79. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD. Plasma total homocysteine and memory in the elderly:the Hordaland Homocysteine Study. Ann Neurol. 2005; 58:847-57.
80. Elias MF, Robbins MA, Budge MM, Elias PK, Brennan SL, Johnston C, Nagy Z, Bates CJ. Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance:the Maine-Syracuse study. Psychosom Med. 2006;68:547-54.
81. Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2003;78:441-7.
82. de Lau LM, Refsum H, Smith AD, Johnston C, Breteler MM. Plasma folate concentration and cognitive performance:Rotterdam Scan Study. Am J Clin Nutr. 2007;86:728-34.
83. Green R, Miller JW. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med. 2005;43:1048-51.
84. Joy S, Kaplan E, Fein D. Speed and memory in the WAIS-III Digit Symbol-Coding subtest across the adult lifespan. Arch Clin Neuropsychol. 2004;19:759-67.
85. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85:193-200.
86. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests. New York:Oxford University Press; 2006.
87. Wallesch CW, Curio N, Galazky I, Jost S, Synowitz H. The neuropsychology of blunt head injury in the early postacute stage:effects of focal lesions and diffuse axonal injury. J Neurotrauma. 2001;18:11-20.
88. Sweeney JE, Slade HP, Ivins RG, Nemeth DG, Ranks DM, Sica RB. Scientific investigation of brain-behavior relationships using the Halstead-Reitan Battery. Appl Neuropsychol. 2007;14:65-72.
89. Almkvist O. Cognitive syndrome(s) in preclinical and clinical vascular dementia. Int Psychogeriatr. 2003;15:Suppl 1:127-31.
90. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75:61-71.
91. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, D'Agostino RB, DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning:the Framingham Heart Study. Arch Neurol. 2006;63:246-50.
92. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, Seeman TE. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults:MacArthur Studies of Successful Aging. Am J Med. 2005;118:161-7.
93. van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJ. Homocysteine and inflammation:predictors of cognitive decline in older persons? Neurobiol Aging. 2010;31:1700-9.
94. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ. 2004;171:897-904.
95. Tangney CC, Tang Y, Evans DA, Morris MC. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology. 2009;72:361-7.
96. Ravaglia G, Forti P, Maioli F, Zanardi V, Dalmonte E, Grossi G, Cucinotta D, Macini P, Caldarera M. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging. 2000;4:218-22.
97. Bernard MA, Nakonezny PA, Kashner TM. The effect of vitamin B12 deficiency on older veterans and its relationship to health. J Am Geriatr Soc. 1998;46:1199-206.
98. Lindeman RD, Romero LJ, Koehler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ. Serum vitamin B12, C and folate concentrations in the New Mexico elder health survey:correlations with cognitive and affective functions. J Am Coll Nutr. 2000;19:68-76.
99. Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the Mini-Mental State Examination in the Framingham Heart Study. J Am Geriatr Soc. Epub 2012 Jul 12.
100. Durga J, van Boxtel MP, Schouten EG, Bots ML, Kok FJ, Verhoef P. Folate and the methylenetetrahydrofolate reductase 677C/T mutation correlate with cognitive performance. Neurobiol Aging. 2006; 27:334-43.
101. Kang JH, Irizarry MC, Grodstein F. Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Epidemiology. 2006; 17:650-7.
102. Jelicic M, Jonker C, Deeg DJ. Effect of low levels of serum vitamin B12 and folic acid on cognitive performance in old age:a population-based study. Dev Neuropsychol. 2001;20:565-71.
103. Tangney CC, Aggarwal NT, Li H, Wilson RS, Decarli C, Evans DA, Morris MC. Vitamin B12, cognition, and brain MRI measures:a cross-sectional examination. Neurology. 2011;77:1276-82.
104. Garcia AA, Haron Y, Evans LR, Smith MG, Freedman M, Roman GC. Metabolic markers of cobalamin deficiency and cognitive function in normal older adults. J Am Geriatr Soc. 2004;52:66-71.
105. Morris MC, Evans DA, Bienias JL, Tangney CC, Hebert LE, Scherr PA, Schneider JA. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol. 2005; 62:641-5.
106. Reynolds EH. Folic acid and the prevention of neural tube defects. Folate has potential to cause harm. BMJ. 1995;311:257.
107. Palca J. Folic acid. Agencies split on nutrition advice. Science. 1992; 257:1857.
108. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5:949-60.
109. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr. 2010 ;91:1733-44. Epub 2010 Mar 31.
110. Clarke R, Sherliker P, Hin H, Molloy AM, Nexo E, Ueland PM, Emmens K, Scott JM, Evans JG. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr. 2008;100:1054-9.
111. Fioravanti M, Ferrario E, Massaia M, Cappa G, Rivolta G, Grossi E, et al. Low folate levels in the cognitive decline of elderly patients and theefficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr. 1998;26:1-13.
112. McMahon JA, Green TJ, SkeaffCM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354:2764-72.
113. Durga J, van BoxtelMP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial:a randomised, double blind, controlled trial. Lancet. 2007;369:208-16.
114. Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, Kljakovic M, Crisp D, Christensen H. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in communitydwelling older adults with depressive symptoms-the Beyond Ageing Project:a randomized controlled trial. Am J Clin Nutr. 2012;95:194-203.
115. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum:acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr. 1997;65:1790-5.
116. Food and Nutrition Board IoM. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC:National Academies Press; 2000.
117. Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, van Staveren WA. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency:a dose-finding trial. Arch Intern Med. 2005;165:1167-72.
118. Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc. 2002;50:1789-95.
119. Pfeiffer CM, Schleicher RL, Johnson CL, Coates PM. Assessing vitamin status in large population surveys by measuring biomarkers and dietary intake-two case studies:folate and vitamin D. Food Nutr Res. 2012;56. Epub 2012 Apr 2.
120. Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr. 2008;88:1602-10.